Ionis Pharmaceuticals Stock Price Prediction
| IONS Stock | USD 32.96 0.06 0.18% |
Momentum 50
Impartial
Oversold | Overbought |
Quarterly Earnings Growth (0.44) | EPS Estimate Next Quarter (0.96) | EPS Estimate Current Year (2.88) | EPS Estimate Next Year (2.31) | Wall Street Target Price 59.5021 |
Using Ionis Pharmaceuticals hype-based prediction, you can estimate the value of Ionis Pharmaceuticals from the perspective of Ionis Pharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Ionis Pharmaceuticals using Ionis Pharmaceuticals' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Ionis using crowd psychology based on the activity and movement of Ionis Pharmaceuticals' stock price.
Ionis Pharmaceuticals Short Interest
An investor who is long Ionis Pharmaceuticals may also wish to track short interest. As short interest increases, investors should be becoming more worried about Ionis Pharmaceuticals and may potentially protect profits, hedge Ionis Pharmaceuticals with its derivative instruments, or be ready for some potential downside.
200 Day MA 39.6256 | Short Percent 0.0943 | Short Ratio 7.45 | Shares Short Prior Month 12.1 M | 50 Day MA 32.8676 |
Ionis Pharmaceuticals Hype to Price Pattern
Investor biases related to Ionis Pharmaceuticals' public news can be used to forecast risks associated with an investment in Ionis. The trend in average sentiment can be used to explain how an investor holding Ionis can time the market purely based on public headlines and social activities around Ionis Pharmaceuticals. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Ionis Pharmaceuticals' market sentiment to its price can help taders to make decisions based on the overall investors consensus about Ionis Pharmaceuticals.
Ionis Pharmaceuticals Implied Volatility | 0.94 |
Ionis Pharmaceuticals' implied volatility exposes the market's sentiment of Ionis Pharmaceuticals stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Ionis Pharmaceuticals' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Ionis Pharmaceuticals stock will not fluctuate a lot when Ionis Pharmaceuticals' options are near their expiration.
The fear of missing out, i.e., FOMO, can cause potential investors in Ionis Pharmaceuticals to buy its stock at a price that has no basis in reality. In that case, they are not buying Ionis because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Ionis Pharmaceuticals after-hype prediction price | USD 32.89 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Prediction based on Rule 16 of the current Ionis contract
Based on the Rule 16, the options market is currently suggesting that Ionis Pharmaceuticals will have an average daily up or down price movement of about 0.0588% per day over the life of the 2025-04-17 option contract. With Ionis Pharmaceuticals trading at USD 32.96, that is roughly USD 0.0194 . If you think that the market is fully incorporating Ionis Pharmaceuticals' daily price movement you should consider acquiring Ionis Pharmaceuticals options at the current volatility level of 0.94%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Ionis |
Ionis Pharmaceuticals After-Hype Price Prediction Density Analysis
As far as predicting the price of Ionis Pharmaceuticals at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Ionis Pharmaceuticals or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Ionis Pharmaceuticals, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Ionis Pharmaceuticals Estimiated After-Hype Price Volatility
In the context of predicting Ionis Pharmaceuticals' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Ionis Pharmaceuticals' historical news coverage. Ionis Pharmaceuticals' after-hype downside and upside margins for the prediction period are 30.38 and 35.40, respectively. We have considered Ionis Pharmaceuticals' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Ionis Pharmaceuticals is very steady at this time. Analysis and calculation of next after-hype price of Ionis Pharmaceuticals is based on 3 months time horizon.
Ionis Pharmaceuticals Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Ionis Pharmaceuticals is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Ionis Pharmaceuticals backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Ionis Pharmaceuticals, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.21 | 2.51 | 0.07 | 0.10 | 9 Events / Month | 12 Events / Month | In about 9 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
32.96 | 32.89 | 0.21 |
|
Ionis Pharmaceuticals Hype Timeline
Ionis Pharmaceuticals is currently traded for 32.96. The entity has historical hype elasticity of -0.07, and average elasticity to hype of competition of -0.1. Ionis is estimated to decline in value after the next headline, with the price expected to drop to 32.89. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next news is expected to be -0.21%, whereas the daily expected return is currently at -0.21%. The volatility of related hype on Ionis Pharmaceuticals is about 518.71%, with the expected price after the next announcement by competition of 32.86. About 99.0% of the company shares are owned by institutional investors. The company has Price/Earnings (P/E) ratio of 101.16. Ionis Pharmaceuticals recorded a loss per share of 3.04. The entity had not issued any dividends in recent years. Given the investment horizon of 90 days the next estimated press release will be in about 9 days. Check out Ionis Pharmaceuticals Basic Forecasting Models to cross-verify your projections.Ionis Pharmaceuticals Related Hype Analysis
Having access to credible news sources related to Ionis Pharmaceuticals' direct competition is more important than ever and may enhance your ability to predict Ionis Pharmaceuticals' future price movements. Getting to know how Ionis Pharmaceuticals' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Ionis Pharmaceuticals may potentially react to the hype associated with one of its peers.
Ionis Pharmaceuticals Additional Predictive Modules
Most predictive techniques to examine Ionis price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Ionis using various technical indicators. When you analyze Ionis charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Ionis Pharmaceuticals Predictive Indicators
The successful prediction of Ionis Pharmaceuticals stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Ionis Pharmaceuticals, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Ionis Pharmaceuticals based on analysis of Ionis Pharmaceuticals hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Ionis Pharmaceuticals's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Ionis Pharmaceuticals's related companies. | 2022 | 2023 | 2024 | 2025 (projected) | Days Sales Outstanding | 15.88 | 45.31 | 47.72 | 45.33 | PTB Ratio | 9.35 | 18.71 | 8.88 | 8.44 |
Story Coverage note for Ionis Pharmaceuticals
The number of cover stories for Ionis Pharmaceuticals depends on current market conditions and Ionis Pharmaceuticals' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Ionis Pharmaceuticals is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Ionis Pharmaceuticals' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Ionis Pharmaceuticals Short Properties
Ionis Pharmaceuticals' future price predictability will typically decrease when Ionis Pharmaceuticals' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Ionis Pharmaceuticals often depends not only on the future outlook of the potential Ionis Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Ionis Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 149.5 M | |
| Cash And Short Term Investments | 2.3 B |
Additional Tools for Ionis Stock Analysis
When running Ionis Pharmaceuticals' price analysis, check to measure Ionis Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ionis Pharmaceuticals is operating at the current time. Most of Ionis Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Ionis Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ionis Pharmaceuticals' price. Additionally, you may evaluate how the addition of Ionis Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.